Advertisement Apria Healthcare to acquire Coram - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Apria Healthcare to acquire Coram

Home medical equipment provider Apria Healthcare has agreed to acquire all the outstanding shares of Colorado-based home infusion company Coram for a cash price of $350 million.

The acquisition will expand Apria’s service offering by creating a nationwide home infusion provider. The transaction also enables Apria to immediately enter the large and rapidly-growing specialty pharmaceutical market, while expanding existing managed care relationships associated with its respiratory/home medical equipment business.

The transaction is conditioned upon obtaining customary, governmental and regulatory approvals and other standard closing conditions.

Apria expects Coram to generate approximately $500 million of revenue in 2008. Apria estimates that the transaction will be dilutive to net after-tax earnings by approximately $3.5 to $5.5 million in 2008, and accretive to 2009 net after-tax earnings by approximately $5 to $6 million.

Lawrence Higby, CEO of Apria Healthcare, said: “This is a transformative event for Apria Healthcare. The transaction supports our strategy of diversifying our service offering by adding and expanding complementary product lines that fit well with our core competencies.”